Polaryx Therapeutics, Inc. Common Stock Share Price
NASDAQ: PLYX
Live Polaryx Therapeutics, Inc. Common Stock Share Price Chart
O H L
Polaryx Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$2.11Low
$2.11High
Markets Today
| Previous Close | $2.14 |
|---|---|
| Open | $2.11 |
| Volume | 10,985 |
| Day's Range | $2.11 - $2.11 |
| 52W Range | NA |
| Market Cap | $101.19 M |
Historical Performance
| 1M Returns | +2.39 |
|---|---|
| 3M Returns | -7.76 |
| 6M Returns | -61.30 |
| 1Y Returns | NA |
| 5Y Returns | NA |
| 10Y Returns | NA |
Polaryx Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $101.19 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
| Market Cap | $101.19 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
Polaryx Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2026 | Jun 2026 | |
|---|---|---|
| Total Revenue + | $0 | $0 |
| Gross Profit + | $0 | $0 |
| Operating Income | -$1.96 M | -$1.38 M |
| EBITDA | -$1.96 M | -$1.38 M |
| Interest Expense | $0 | $0 |
| Depreciation | $0 | $0 |
| Income Before Tax | -$2.54 M | -$1.38 M |
| Income Tax Expense | $0 | $0 |
| Net Income + | -$2.54 M | -$1.38 M |
| Net Profit Margin | - | - |
Polaryx Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2026 | Jun 2026 | |
|---|---|---|
| Share Capital | $5.00 K | $5.00 K |
| Reserve & Surplus | -$102.18 M | -$103.56 M |
| Non-Current Liabilities | $0 | $0 |
| Current Liabilities | $1.01 M | $873.00 K |
| Total Liabilities | $1.01 M | $873.00 K |
| Fixed Assets | $0 | $0 |
| Current Assets | $3.50 M | $11.81 M |
| Total Assets | $3.50 M | $11.81 M |
Polaryx Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Mar 2026 | Jun 2026 | |
|---|---|---|
| Net Income | -$2.54 M | -$1.38 M |
| Operating Cash Flow | -$2.06 M | -$1.37 M |
| Investing Cash Flow | $0 | $0 |
| Financing Cash Flow | $0 | $9.83 M |
| Change in Cash | -$2.06 M | $8.46 M |
Polaryx Therapeutics, Inc. Common Stock Return Calculator
The Polaryx Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Polaryx Therapeutics, Inc. Common Stock
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal storage disorders segment consists of the Company's costs associated with the preclinical and clinical development of the Company's product candidates.
Popular Stocks
FAQs
What is the share price of Polaryx Therapeutics, Inc. Common Stock today?
Polaryx Therapeutics, Inc. Common Stock (PLYX) share price as of September 18, 2026 is $2.02. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Polaryx Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the Polaryx Therapeutics, Inc. Common Stock (PLYX) Share by opening an international trading account with Angel One.
How can I purchase Polaryx Therapeutics, Inc. Common Stock shares in India?
Purchasing Polaryx Therapeutics, Inc. Common Stock (PLYX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Polaryx Therapeutics, Inc. Common Stock (PLYX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Polaryx Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of Polaryx Therapeutics, Inc. Common Stock (PLYX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Polaryx Therapeutics, Inc. Common Stock?
The market capitalization of Polaryx Therapeutics, Inc. Common Stock on September 18, 2026, is $101.19 M.
In which sector Polaryx Therapeutics, Inc. Common Stock belongs?
Polaryx Therapeutics, Inc. Common Stock operates in the null sector, specifically in the null industry.
What documents are required to invest in Polaryx Therapeutics, Inc. Common Stock stocks?
In order to invest in Polaryx Therapeutics, Inc. Common Stock (PLYX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
